| scholarly article | Q13442814 |
| P50 | author | Mónica Vázquez-Del Mercado | Q51803035 |
| Rosa Elena Navarro-Hernández | Q57341325 | ||
| Jorge Castro-Albarran | Q57365501 | ||
| Eduardo Gomez Bañuelos | Q83207577 | ||
| Fernanda-Isadora Corona Meraz | Q85620761 | ||
| Perla-Monserrat Madrigal-Ruíz | Q88128732 | ||
| Sandra-Luz Ruíz-Quezada | Q88128734 | ||
| Beatriz-Teresita Martín-Marquez | Q88128739 | ||
| P2093 | author name string | Flavio Sandoval-García | |
| Luis-Javier Flores-Alvarado | |||
| P2860 | cites work | Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 |
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Pathophysiology of human visceral obesity: an update | Q26864356 | ||
| Evaluation of methods for the measurement of low-density lipoprotein cholesterol. | Q29547378 | ||
| Obesity: preventing and managing the global epidemic. Report of a WHO consultation | Q29547404 | ||
| Impact of obesity on cardiovascular disease. | Q30371908 | ||
| Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals. | Q33554854 | ||
| Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. | Q33751624 | ||
| Low levels of CD36 in peripheral blood monocytes in subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study in a Mexican population. | Q33805096 | ||
| Population distribution of the sagittal abdominal diameter (SAD) from a representative sample of US adults: comparison of SAD, waist circumference and body mass index for identifying dysglycemia | Q34278227 | ||
| A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling | Q34530236 | ||
| miR-141 contributes to fetal growth restriction by regulating PLAG1 expression | Q34648245 | ||
| A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples | Q34721532 | ||
| The assessment of insulin resistance in man. | Q34722579 | ||
| The discovery of LOX-1, its ligands and clinical significance | Q35475499 | ||
| Assessing cardiometabolic risk in middle-aged adults using body mass index and waist-height ratio: are two indices better than one? A cross-sectional study. | Q36035055 | ||
| Association between plasma sLOX-1 concentration and arterial stiffness in middle-aged and older individuals | Q36049150 | ||
| Macrophage-mediated inflammation in metabolic disease | Q36060408 | ||
| Highly upregulated expression of CD36 and MSR1 in circulating monocytes of patients with acute coronary syndromes | Q36095925 | ||
| Sagittal abdominal diameter as a new predictor for incident diabetes | Q36560404 | ||
| Abdominal obesity and metabolic syndrome | Q36682671 | ||
| CD36 and macrophages in atherosclerosis | Q36795000 | ||
| Inverse Relationship of the CMKLR1 Relative Expression and Chemerin Serum Levels in Obesity with Dysmetabolic Phenotype and Insulin Resistance. | Q36893067 | ||
| Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk | Q37115260 | ||
| Elevated soluble lectin-like oxidized LDL receptor-1 (sLOX-1) levels in obese postmenopausal women | Q37181325 | ||
| Waist circumference measurement in clinical practice | Q37235893 | ||
| Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans. | Q37370209 | ||
| Scavenger receptors in homeostasis and immunity | Q38127564 | ||
| Soluble CD36 (sCD36) clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes risk | Q43170056 | ||
| Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels predict percutaneous coronary intervention-related periprocedural myocardial infarction in stable patients undergoing elective native single-vessel PCI. | Q45045801 | ||
| LOX-1 is a novel marker for peripheral artery disease in patients with type 2 diabetes. | Q45850788 | ||
| Weight reduction can decrease circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in overweight middle-aged men. | Q45932493 | ||
| Receptor CD36 expression on peripheral blood monocytes in women with visceral obesity | Q46060573 | ||
| A standardized technique for the blood sedimentation test. 1935. | Q46095313 | ||
| Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant men. | Q46155246 | ||
| Circulating soluble CD36 is a novel marker of liver injury in subjects with altered glucose tolerance. | Q46369931 | ||
| Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus | Q46648050 | ||
| Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment. | Q46901919 | ||
| CD36 T188G gene polymorphism and severe falciparum malaria in India | Q47892019 | ||
| Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance. | Q51490660 | ||
| Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 | ||
| Two-dimensional predictive equation to classify visceral obesity in clinical practice. | Q51935716 | ||
| Choosing an index for abdominal obesity: an opportunity for epidemiologic clarification. | Q52396797 | ||
| Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. | Q53183515 | ||
| Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy. | Q53628909 | ||
| Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease. | Q54739177 | ||
| Separation of leukocytes from blood and bone marrow. Introduction | Q72181173 | ||
| Identification of soluble forms of lectin-like oxidized LDL receptor-1 | Q73536903 | ||
| Obesity: Insensitive issue | Q74441494 | ||
| Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican population | Q77463151 | ||
| Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis | Q80976759 | ||
| The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia | Q83311143 | ||
| The association of lectin-like oxidized LDL receptor 1 (LOX-1) K167N and 3'UTR188CT polymorphisms with maternal plasma soluble LOX-1 levels and preeclampsia risk in Turkish population | Q85273527 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 5678946 | |
| P577 | publication date | 2016-07-25 | |
| P1433 | published in | Journal of Diabetes Research | Q26841822 |
| P1476 | title | Low CD36 and LOX-1 Levels and CD36 Gene Subexpression Are Associated with Metabolic Dysregulation in Older Individuals with Abdominal Obesity | |
| P478 | volume | 2016 |
| Q64114784 | Sex differences in gene expression related to antipsychotic induced weight gain | cites work | P2860 |
Search more.